The market for psychedelic drugs to treat mental health conditions gets a big buy signal
Eli Lilly's acquisition of psychedelic drug maker AtaiBeckley extends Big Pharma's embrace of a stigmatized class of medications for treating mental health.
The Source
CNBC
Business
Jamie Dimon says markets underestimate risks and he wouldn’t buy stocks or Treasurys at current prices
CNBC·1h ago·3 min read
US
Trump imposing 50% tariffs on certain Canadian goods over alleged trade discrimination
CNBC·2h ago·3 min read
Business
The FDA made a big reversal in its cyclosporiasis probe, but it still thinks iceberg lettuce is to blame
CNBC·6h ago·3 min read
US
Trump says Netanyahu won’t be arrested in New York, pushing back on Mamdani
CNBC·6h ago·3 min read
Related
On this beat
Health
The Sewer Knows What You Ate
TNYT·5h ago·3 min read
Health
They used GLP-1s to lose weight. They ended up in treatment for anorexia.
TWSJ·9h ago·3 min read
Health
The Best Genetic Risk Tools Don’t Work Equally for Everyone
TNYT·15h ago·3 min read
Health
Five cups of coffee a day is fine for most adults, heart association says, as evidence grows about the beverage’s benefits
TWSJ·15h ago·3 min read
